Search results
Halozyme Announces Bristol Myers Squibb Received Updated Action Date from the U.S. Food and Drug...
FOX 23 News Albany· 1 day agoHalozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Bristol Myers Squibb was reassigned a Prescription Drug User Fee Act goal date from the U.S. Food and Drug Administration ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 10 hours agoNeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb PR Newswire LONDON, May 22, 2024 Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression
At 44, Mindy Kaling Shares Her Diet and Fitness Routine Amid Weight Loss
Prevention via AOL· 1 day agoMindy Kaling Shares Her Favorite WorkoutSantiago Felipe - Getty Images Mindy Kaling opens up about...
1 Stock I Wouldn't Touch With a 10-Foot Pole | The Motley Fool
The Motley Fool· 1 day agoThere are many positive things about Bristol Myers Squibb (BMY -2.51%) and its stock. It won't be...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks via Yahoo Finance· 6 days agoBristol Myers Squibb (BMY) obtains FDA approval for the label expansion of CAR T cell therapy...
TD Cowen maintains $67 target on Bristol-Myers Squibb By Investing.com
Investing.com· 6 days agoOn Thursday, TD (TSX:TD) Cowen sustained its Hold rating on shares of Bristol-Myers Squibb Co....
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...
Morningstar· 7 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical
FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously...
Benzinga· 6 days agoWednesday, the FDA granted accelerated approval to Bristol Myers Squibb Co’s BMY Breyanzi...
Cencora Provides Notice of Data Breach Affecting Bristol Myers Squibb Customers’ Information | JD...
JD Supra· 2 days agoOn May 17, 2024, Cencora, Inc. filed a notice of data breach with the Attorney General of Massachusetts after learning that a cyberattack targeting the company’s IT network resulted in an unauthorized ...
BMS reports four-year data from psoriasis treatment extension trial
Clinical Trials Arena via Yahoo Finance· 5 days agoBristol Myers Squibb (BMS) has revealed four-year data from the POETYK PSO long-term extension (LTE)...
